Claire V Murphy: Influence Statistics

Claire V Murphy

Claire V Murphy

Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio | Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, ...

Claire V Murphy: Expert Impact

Concepts for which Claire V Murphy has direct influence: Burn injury , Trauma patients , Glycemic control , Nebulized heparin , Hospital mortality , Critically patients , Septic shock .

Claire V Murphy: KOL impact

Concepts related to the work of other authors for which for which Claire V Murphy has influence: Septic shock , Fluid overload , Acute kidney injury , Critically patients , Severe sepsis , Intensive unit , Hospital mortality .

KOL Resume for Claire V Murphy

Year
2022

Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio

2021

Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America.

2020

Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, United States.

The Ohio State University Wexner Medical Center, Columbus, OH, USA

2019

Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W 10th Ave, Columbus, OH 43210, USA. Electronic address:

2018

Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 W. 10th Avenue, Columbus, OH 43210, USA. Electronic address:

The Ohio State University Wexner Medical Center, Columbus, OH, The Ohio State University Medical Center, Columbus, OH

2017

From the The Ohio State University College of Pharmacy, Columbus; Department of Clinical Nutrition, The Ohio State University Wexner Medical Center, Columbus; Department of Surgery, Division of Trauma, Critical Care and Burn, The Ohio State University Wexner Medical Center, Columbus; and Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus.

Department of Pharmacy, The Ohio State University Wexner Medical Center, 410 w. 10th Avenue, Columbus, OH 43210, USA

2016

Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

2015

The Ohio State University Wexner Medical Center, Columbus, OH

2014

Methodist University Hospital, Methodist Healthcare, Memphis, Tennessee (Drs Mohrien and Jones); Department of Clinical Pharmacy, University of Tennessee Health Sciences Center, Memphis (Dr Jones); and The Ohio State University Wexner Medical Center, Columbus (Ms MacDermott and Dr Murphy).

Department of Pharmacy, The Ohio State University College of Medicine, Columbus, Ohio, USA

2013

From the Department of Pharmacy, Methodist Healthcare, University of Tennessee Health Sciences Center, Memphis; Center for Biostatistics, the Ohio State University, Columbus; Department of Surgery, the Ohio State University Medical Center, Columbus; and Department of Surgery, Wright State University Boonshoft School of Medicine, Dayton; and Department of Pharmacy, the Ohio State University Medical Center, Columbus.

The Ohio State University Wexner Medical Center, Columbus

Department of Pharmacy, Wexner Medical Center at the Ohio State University, USA

2012

The Ohio State University, Columbus, OH, USA

Department of Clinical Pharmacy, Ohio State University Medical Center, Columbus, Ohio

2011

Department of Pharmacy and Center of Critical Care, The Ohio State University Medical Center, Room 368, Doan Hall, 410 West Tenth Avenue, Columbus, OH 43210, USA

Claire V Murphy, PharmD BCPS, Specialty Practice Pharmacist, The Ohio State University Medical Center; Clinical Assistant Professor, The Ohio State University

2010

Department of Pharmacy, The Ohio State University Medical Center, Columbus, OH, USA

The Ohio State University, Columbus, OH

2009

The Ohio State University Medical Center

Department of Pharmacy, Mayo Clinic, Rochester, MN

Prominent publications by Claire V Murphy

KOL-Index: 10624 . OBJECTIVE: To evaluate recent comparative studies regarding the safety and efficacy of dexmedetomidine in adults. DATA SOURCES: Articles evaluating safety and efficacy of dexmedetomidine were identified from an English-language MEDLINE search (1996-July 2009), with a focus on data published since our previous review in 2007 to the present. MeSH terms included dexmedetomidine, medetomidine, ...
Known for Dexmedetomidine Delirium | Critically Patients | Efficacy Safety | Critical Illness
KOL-Index: 10594 . BACKGROUND: Dexmedetomidine is an α(2)-receptor agonist used for sedation in the intensive care unit (ICU). Although dexmedetomidine is labeled for sedation in critically ill patients at doses up to 0.7 μg/kg/h, recent studies have used more liberal dosing regimens. However, to our knowledge, no study has assessed the clinical impact of doses greater than 0.7 μg/kg/h when compared to doses ...
Known for Dose Dexmedetomidine | Hypotension Bradycardia | Intensive Unit | Goal Sedation
KOL-Index: 10095 . STUDY OBJECTIVES: To determine the frequency of nephrotoxicity associated with colistin therapy by using a standardized definition and to identify risk factors for colistin-induced nephrotoxicity in critically ill patients. DESIGN: Single-center, retrospective cohort analysis. SETTING: University-affiliated tertiary care center. PATIENTS: Forty-nine adults admitted to an intensive care ...
Known for Intravenous Colistin | Nephrotoxicity Patients | Intensive Unit | Kidney Disease
KOL-Index: 9064 . BACKGROUND: One of the hallmarks of modern medicine is the improving management of chronic health conditions. Long-term control of chronic disease entails increasing utilization of multiple medications and resultant polypharmacy. The goal of this study is to improve our understanding of the impact of polypharmacy on outcomes in trauma patients 45 years and older. MATERIALS AND METHODS: ...
Known for Trauma Patients | Injury Polypharmacy | Complications Cps | Comorbid Conditions
KOL-Index: 9015 . BACKGROUND: Recent studies have suggested that early goal-directed resuscitation of patients with septic shock and conservative fluid management of patients with acute lung injury (ALI) can improve outcomes. Because these may be seen as potentially conflicting practices, we set out to determine the influence of fluid management on the outcomes of patients with septic shock complicated by ...
Known for Fluid Management | Lung Injury | Septic Shock | Hospital Mortality
KOL-Index: 8707 . BACKGROUND: Obesity is endemic in the United States and obese patients are at increased risk of thromboembolism but little data are available for dosing unfractionated heparin (UFH). We evaluated the relationship between obesity and UFH efficacy during critical illness by examining UFH infusions in non-obese, obese, and morbidly obese critically ill patients. MATERIALS AND METHODS: ...
Known for Heparin Dosing | Actual Body Weight | Obese Patients | Therapeutic Aptt
KOL-Index: 8272 . OBJECTIVES: To determine the association between comorbidity-polypharmacy score (CPS) and clinical outcomes in a large sample of older trauma patients, focusing on outcome prognostication. DESIGN: The CPS combines number of preinjury medications and comorbidities to more objectively quantify the severity of comorbid conditions. SETTING: An urban tertiary care level 1 trauma center in the ...
Known for Trauma Patients | Higher Cps | Discharge Facility | Mortality Complications
KOL-Index: 8165 . BACKGROUND: The incidence of multi-drug resistant (MDR) gram-negative (GN) organisms including Pseudomonas and Acinetobacter spp has increased in the last decade, prompting re-evaluation of colistin for the management of these infections. Aerosolized colistin as an adjunct to intravenous therapy is a current option for the management of MDR-GN pneumonia, although data supporting this ...
Known for Aerosolized Colistin | Clinical Cure | Critically Patients | Mdrgn Pneumonia
KOL-Index: 8153 . Currently, in vitro synergy with colistin has not translated into improved clinical outcomes. This study aimed to compare colistin combination therapy to colistin monotherapy in critically ill patients with multi-drug resistant gram-negative (MDR-GN) pneumonia. This was a retrospective analysis of critically ill adult patients receiving intravenous colistin for MDR-GN pneumonia comparing ...
Known for Combination Therapy | Clinical Cure | Resistant Gram | Critically Patients
KOL-Index: 7488 . OBJECTIVE: Post-emergency department triage of older trauma patients continues to be challenging, as morbidity and mortality for any given level of injury severity tend to increase with age. The comorbidity-polypharmacy score (CPS) combines the number of pre-injury medications with the number of comorbidities to estimate the severity of comorbid conditions. This retrospective study ...
Known for Injury Severity | Polypharmacy Score | Cps Patients | Comorbid Conditions
KOL-Index: 6929 . Glucose management in patients with burn injury is often difficult because of their hypermetabolic state with associated hyperglycemia, hyperinsulinemia, and insulin resistance. Recent studies suggest that time to glycemic control is associated with improved outcomes. The authors sought to determine the influence of early glycemic control on the outcomes of critically ill patients with ...
Known for Burn Injury | Early Glycemic Control | Critically Patients | Insulin Resistance
KOL-Index: 6667 . Currently, there have been few studies that have evaluated the incidence of vitamin D deficiency in adult burn patients or correlated vitamin D levels with burn-related outcomes. The primary objective of the study was to identify the incidence of vitamin D deficiency and insufficiency in an adult burn population. The secondary objective was to determine the impact of vitamin D deficiency ...
Known for Burn Injury | Vitamin Deficiency | Retrospective Studies | Primary Objective
KOL-Index: 5869 . INTRODUCTION: Emergence of multidrug-resistant (MDR) gram-negative (GN) pathogens and lack of novel antibiotics have increased the use of colistin, despite unknown optimal dosing. This study aimed to evaluate the safety and efficacy of a colistin loading dose, high-dose (LDHD) maintenance regimen in patients with MDR-GN pneumonia. METHODS: A retrospective cohort analysis was performed ...
Known for Colistin Loading Dose | Critically Patients | Clinical Cure | Resistant Gram
KOL-Index: 5755 . Argatroban is a parenteral direct thrombin inhibitor labeled for anticoagulation in patients with confirmed or suspected heparin-induced thrombocytopenia in the United States. Currently there are no studies evaluating bleeding risk factors in Intensive Care Unit patients.To determine bleeding risk factors associated with argatroban therapy in the critically ill. Critically ill patients ...
Known for Argatroban Therapy | Bleeding Risk | Critically Patients | Retrospective Studies

Key People For Burn Injury

Top KOLs in the world
#1
David Newcomb Herndon
inhalation injury burned children burn patients
#2
Ronald G MD Tompkins
burn injury skeletal muscle insulin resistance
#3
Marc Gerhard Jeschke
burn injury wound healing adipose tissue
#4
Richard L Gamelli
burn injury wound healing bone marrow
#5
Steven E Wolf
severe burn growth hormone inhalation injury
#6
Nicole S Gibran
burn injury wound healing hypertrophic scar

Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio | Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, United States of America. | Columbus | Department of Pharmacy, The Ohio S